Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fate Therapeutics
Biotech
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
J&J exec to retire after 17 years. Bayer’s top biotech leader departs. Former Kite exec takes the reins of new biotech.
Gabrielle Masson
,
Andrea Park
,
Fraiser Kansteiner
Jun 14, 2024 8:30am
Fate resets as J&J deal ends, cutting pipeline and head count
Jan 6, 2023 6:50am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Bristol Myers Squibb-backed Clade nabs a meaty $87M series A
Nov 3, 2021 7:00am
Fate Therapeutics' stock drops on blood cancer readout
Aug 20, 2021 8:20am
Fate Therapeutics sees CSO and biotech veteran Shoemaker retire
Mar 25, 2021 7:45am